Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efesovir vs Remdesivir in Hospitalized COVID-19
NCT05060705Phase 2Not yet recruiting
- Sponsor
- Scientific Center for Anti-Infectious Drugs
- Start
- Dec 2025
- Primary completion
- Apr 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Efesovir in coronavirus disease 2019 (COVID-19), sponsored by Scientific Center for Anti-Infectious Drugs. Planned start Dec 2025; status: not yet recruiting.
02
Drugs
Efesovir
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05060705.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05060705.